(1)
Corrigendum: Treatments of Advanced Non‑Small Cell Lung Cancer (NSCLC) in an Italian Center: Drug Utilization and the Treatment Costs of Innovative Drugs. FE 2019, 20 (1). https://doi.org/10.7175/fe.v20i1.1438.